Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 11 » Issue 1

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)

Total article views   HTML views PDF downloads Totals
29,735 Dovepress* 23,186+ 2,848 26,034
PubMed Central* 6,549 2,828 9,377
Totals 29,735 5,676 35,411
*Since 3 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 2 6

View citations on PubMed Central and Google Scholar